Search results
Foreword
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
3 years ago
Article
Author(s):
Ioannis Mastoris
,
Ersilia M DeFilippis
,
Trejeeve Martyn
,
et al
Added:
1 year ago
Author(s):
Davide Margonato
,
Simone Mazzetti
,
Renata De Maria
,
et al
Added:
3 years ago
Heart failure (HF) is a complex syndrome caused by functional and structural abnormalities of the left ventricle (LV) resulting in a combination of typical signs and symptoms. Historically, HF has been classified according to LV ejection fraction (EF) as either HF with reduced EF (HFrEF; LVEF <40%) or HF with preserved EF (HFpEF; LVEF >50%).1,2 The 2016 European Society of Cardiology (ESC)…
View more
Author(s):
David R Thompson
,
Chantal F Ski
,
Alexander M Clark
,
et al
Added:
1 year ago
Author(s):
Gianluigi Savarese
,
Lars H Lund
Added:
3 years ago
Heart failure (HF) is a complex clinical syndrome characterised by the reduced ability of the heart to pump and/or fill with blood.1,2 From a physiological point of view, HF can be defined as an inadequate cardiac output to meet metabolic demands or adequate cardiac output secondary to compensatory neurohormonal activation (generally manifesting as increased left ventricular filling pressure).2…
View more
Author(s):
Hans-Peter Brunner-La Rocca
,
Sandra Sanders-van Wijk
Added:
3 years ago
Natriuretic peptides (NPs) are well established in the diagnostic process of heart failure (HF). Low levels of NPs are particularly useful to exclude heart failure (HF). Numerous studies, predominantly in patients presenting with acute onset of symptoms suspected of HF, have convincingly shown the value of NPs in this regard. A meta-analysis published in 2015 clearly summarised the value of brain…
View more
Author(s):
Sabina Frljak
,
Gregor Poglajen
,
Bojan Vrtovec
Added:
2 years ago
Author(s):
Maria Stefil
,
Matthew Dixon
,
Jameela Bahar
,
et al
Added:
1 year ago
Author(s):
Sam Hayman
,
John J Atherton
Added:
3 years ago
Heart failure (HF) is associated with significant morbidity and mortality and confers a major economic burden.1 Large randomised controlled trials (RCTs) have demonstrated that inhibition of the renin–angiotensin– aldosterone and sympathetic nervous systems improve outcomes in patients with HF and a reduced left ventricular ejection fraction (HFrEF) (see Figure 1),2–9 with clinical guidelines…
View more
Author(s):
Nicole Ebner
,
Stephan Von Haehling
Added:
3 years ago
Iron is an essential trace element that is present in a number of molecular systems, and it is increasingly recognised as an important cofactor for a variety of cell systems.1 It has been acknowledged that iron plays an important role in oxygen transport, as well as in cell growth and proliferation. In recent years, more insight has been gained into iron physiology and the regulation of cellular…
View more